Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
A Phase II study aimed to evaluate the efficacy and toxicity of preoperative
chemoradiotherapy with capecitabine in locally advanced resectable rectal cancer.